Aptevo Therapeutics Inc. (APVO)
Largest Insider Buys in Sector
APVO Stock Price History Chart
APVO Stock Performance
About Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a …
Insider Activity of Aptevo Therapeutics Inc.
Over the last 12 months, insiders at Aptevo Therapeutics Inc. have bought $0 and sold $0 worth of Aptevo Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Aptevo Therapeutics Inc. have bought $49.69M and sold $16.87M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 348,554 shares for transaction amount of $7.92M was made by TANG KEVIN C (10 percent owner) on 2020‑11‑06.
List of Insider Buy and Sell Transactions, Aptevo Therapeutics Inc.
| 2021-11-23 | Sale | 921,336 12.987% | $11.25 | $10.37M | -73.69% | |||
| 2021-11-22 | Sale | 10 percent owner | 255,331 5.9122% | $7.03 | $1.8M | -30.86% | ||
| 2021-11-19 | Sale | 10 percent owner | 213,800 4.7422% | $7.59 | $1.62M | -38.63% | ||
| 2021-11-18 | Sale | 10 percent owner | 369,533 8.1153% | $8.34 | $3.08M | -44.69% | ||
| 2020-11-06 | 10 percent owner | 348,554 7.5668% | $22.73 | $7.92M | +8.23% | |||
| 2020-11-05 | 10 percent owner | 1.25M 25.0765% | $18.78 | $23.5M | +20.82% | |||
| 2020-11-04 | 10 percent owner | 1.27M 24.3464% | $14.34 | $18.27M | +50.91% | |||
| 2019-08-16 | SVP Operations, CMO | 50,000 0.1097% | $0.76 | $38,000 | -25.67% | |||
| 2019-08-12 | director | 200,000 0.4342% | $0.76 | $151,040 | -25.24% | |||
| 2019-07-29 | Board of Directors | 110,030 0.2409% | $0.83 | $91,721 | -31.45% | |||
| 2019-07-23 | Board of Directors | 20,000 0.0452% | $0.90 | $17,992 | -34.35% | |||
| 2019-07-22 | Board of Directors | 60,000 0.1331% | $0.89 | $53,202 | -34.06% | |||
| 2019-07-19 | Board of Directors | 52,920 0.1212% | $0.90 | $47,480 | -33.33% | |||
| 2019-07-18 | Board of Directors | 28,808 0.0638% | $0.87 | $25,193 | -33.40% | |||
| 2019-07-17 | Board of Directors | 38,272 0.085% | $0.87 | $33,408 | -32.68% | |||
| 2019-07-16 | Board of Directors | 22,750 0.0486% | $0.85 | $19,324 | -33.41% | |||
| 2019-07-11 | Board of Directors | 29,382 0.0649% | $0.85 | $24,907 | -30.51% | |||
| 2019-07-10 | director | 37,838 0.0843% | $0.85 | $32,117 | -30.01% | |||
| 2019-06-25 | Board of Directors | 33,334 0.0753% | $0.90 | $30,001 | -33.16% | |||
| 2019-06-14 | President and CEO | 100,000 0.2219% | $0.88 | $88,000 | -30.63% |
Institutional Investor Ownership
| Tower Research Capital | $6,209.00 | 0.02 | 1,324 | -90.31% | -$57,850.62 | <0.0001 | |
| BlackRock | $4,174.00 | 0.01 | 890 | -98.09% | -$214,538.91 | <0.0001 | |
| Morgan Stanley | $910.00 | <0.01 | 194 | -98.29% | -$52,423.50 | <0.0001 | |
| Qube Research & Technologies | $469.00 | <0.01 | 100 | New | +$469.00 | <0.0001 | |
| Advisor Group Holdings Inc | $211.00 | <0.01 | 45 | +50% | +$70.33 | <0.0001 |